Drug Profile
Research programme: cardiovascular, metabolic and CNS disorder therapeutics - GVK BIO/Moulder Center for Drug Discovery Research
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GVK BIO; Moulder Center for Drug Discovery Research
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cardiovascular disorders; CNS disorders; Metabolic disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cardiovascular-disorders in India
- 16 Jul 2016 No recent reports of development identified for research development in Cardiovascular-disorders in USA
- 16 Jul 2016 No recent reports of development identified for research development in CNS-disorders in India